{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-071253","form_type":"8-K","ticker":"IMNM","cik":"0001472012","company_name":"Immunome Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.562448+00:00","generated_at":"2026-06-01T04:35:24.580878+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Immunome stockholders elect Siegall and Schafer as Class I directors; E&Y ratified","bullets":["Clay B. Siegall elected with 43,295,914 votes for, 80,139 withheld; broker non-votes 6,682,195.","Carol A. Schafer elected with 33,452,580 votes for, 9,923,473 withheld; broker non-votes 6,682,195.","Ratification of Ernst & Young as auditor for FY2024: 50,008,641 for, 29,664 against, 19,943 abstain; no broker non-votes.","Annual Meeting held June 12, 2024; 59,943,368 shares outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-071253","json":"https://secwatch.observer/filing/0001104659-24-071253.json","markdown":"https://secwatch.observer/filing/0001104659-24-071253.md","text":"https://secwatch.observer/filing/0001104659-24-071253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472012/000110465924071253/0001104659-24-071253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472012/000110465924071253/tm2417104d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:35:24.580878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}